1511 related articles for article (PubMed ID: 23644932)
1. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
2. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
3. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2023 Sep; 9(9):CD000254. PubMed ID: 37702300
[TBL] [Abstract][Full Text] [Related]
5. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
7. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
8. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of age-related macular degeneration: an update for pharmacists.
Marshall LL; Roach JM
Consult Pharm; 2013 Nov; 28(11):723-37. PubMed ID: 24217192
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
Age-Related Eye Disease Study Research Group
Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942
[TBL] [Abstract][Full Text] [Related]
11. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
; Chew EY; SanGiovanni JP; Ferris FL; Wong WT; Agron E; Clemons TE; Sperduto R; Danis R; Chandra SR; Blodi BA; Domalpally A; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Friberg TR; Rosenfeld PJ; Toth CA; Bernstein P
JAMA Ophthalmol; 2013 Jul; 131(7):843-50. PubMed ID: 23645227
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
[TBL] [Abstract][Full Text] [Related]
13. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
14. An eye on nutrition: The role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract.
McCusker MM; Durrani K; Payette MJ; Suchecki J
Clin Dermatol; 2016; 34(2):276-85. PubMed ID: 26903189
[TBL] [Abstract][Full Text] [Related]
15. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
[TBL] [Abstract][Full Text] [Related]
16. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
; Papudesu C; Clemons TE; Agrón E; Chew EY
Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Kurinij N; Davis MD;
Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353
[TBL] [Abstract][Full Text] [Related]
18. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study.
Chiu CJ; Milton RC; Klein R; Gensler G; Taylor A
Ophthalmology; 2009 May; 116(5):939-46. PubMed ID: 19410952
[TBL] [Abstract][Full Text] [Related]
19. Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.
Agrón E; Mares J; Clemons TE; Swaroop A; Chew EY; Keenan TDL;
Ophthalmology; 2021 Mar; 128(3):425-442. PubMed ID: 32858063
[TBL] [Abstract][Full Text] [Related]
20. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
